Eli Lilly Requests Emergency Use Authorization For Antibody Treatment
Indianapolis-based Eli Lilly has requested emergency use authorization, from the Food and Drug Administration, for its COVID-19 single antibody treatment. |!| Indianapolis
Indianapolis-based Eli Lilly has requested emergency use authorization, from the Food and Drug Administration, for its COVID-19 single antibody treatment. |!| Indianapolis